Showing results (1151-1160 of 1,585) with videos related to

Sort By:
Pageof 159
Cancer|September 1, 2010
Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumabJorge A Garcia, Thomas E Hutson, Paul Elson, et al.
Journal of Clinical Microbiology|November 1, 1996
Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutinationJ L Staneck, L S Weckbach, S D Allen, et al.
Spine Deformity|August 12, 2020
Utilization of the American Society of Anesthesiologists (ASA) classification system in evaluating outcomes and costs following deformity spine proceduresAlexander J Schupper, William H Shuman, Rebecca B Baron, et al.
Plos One|July 1, 2024
All hands on deck during the COVID-19 pandemic. Maintaining face-to-face medical education and clinical placementsHilary Humphreys, Ronan Baxter, Judith Gilroy, et al.
Psychiatric Services (Washington, D.C.)|April 11, 2025
Adapting the Project ECHO Model for Providers Treating Trauma-Related Problems: Evaluation and Lessons LearnedKristen P Lindgren, Emily R Dworkin, Sophia Robinson, et al.
Experimental Hematology|May 23, 2009
In vivo inactivation of MASTL kinase results in thrombocytopeniaH Jan Johnson, Manish J Gandhi, Ebrahim Shafizadeh, et al.
Journal of Clinical Microbiology|April 13, 2018
Quantitative Thresholds Enable Accurate Identification of Clostridium difficile Infection by the Luminex xTAG Gastrointestinal Pathogen PanelSixto M Leal, Elena B Popowitch, Kara J Levinson, et al.
Journal of Health Communication|July 29, 2008
A framework for health numeracy: how patients use quantitative skills in health careMarilyn M Schapira, Kathlyn E Fletcher, Mary Ann Gilligan, et al.
Clinical Genitourinary Cancer|August 18, 2020
Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage MigrationIris Y Sheng, Wei Wei, Yu-Wei Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2012
Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancerAllan Price, Ann Yellowlees, Catriona Keerie, et al.
Pageof 159